TY - JOUR AU - Wyatt, R. J. AU - Julian, B. A. PY - 2013 DA - 2013// TI - IgA nephropathy JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMra1206793 DO - 10.1056/NEJMra1206793 ID - Wyatt2013 ER - TY - JOUR AU - Li, L. S. AU - Liu, Z. H. PY - 2004 DA - 2004// TI - Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies JO - Kidney Int VL - 66 UR - https://doi.org/10.1111/j.1523-1755.2004.00837.x DO - 10.1111/j.1523-1755.2004.00837.x ID - Li2004 ER - TY - JOUR AU - Le, W. AU - Liang, S. AU - Hu, Y. PY - 2012 DA - 2012// TI - Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population JO - Nephrol Dial Transplant VL - 27 UR - https://doi.org/10.1093/ndt/gfr527 DO - 10.1093/ndt/gfr527 ID - Le2012 ER - TY - JOUR AU - Reich, H. N. AU - Troyanov, S. AU - Scholey, J. W. AU - Cattran, D. C. PY - 2007 DA - 2007// TI - Toronto glomerulonephritis registry. remission of proteinuria improves prognosis in IgA nephropathy JO - J Am Soc Nephrol VL - 18 UR - https://doi.org/10.1681/ASN.2007050526 DO - 10.1681/ASN.2007050526 ID - Reich2007 ER - TY - JOUR AU - Lv, J. AU - Shi, S. AU - Xu, D. AU - Zhang, H. AU - Troyanov, S. AU - Cattran, D. C. AU - Wang, H. PY - 2013 DA - 2013// TI - Evaluation of the oxford classification of IgA nephropathy: a systematic review and meta-analysis JO - Am J Kidney Dis VL - 62 UR - https://doi.org/10.1053/j.ajkd.2013.04.021 DO - 10.1053/j.ajkd.2013.04.021 ID - Lv2013 ER - TY - JOUR AU - Zhang, C. AU - Zeng, X. AU - Li, Z. AU - Wang, Z. AU - Li, S. PY - 2015 DA - 2015// TI - Immunoglobulin A nephropathy: current progress and future directions JO - Transl Res VL - 166 UR - https://doi.org/10.1016/j.trsl.2015.02.007 DO - 10.1016/j.trsl.2015.02.007 ID - Zhang2015 ER - TY - JOUR AU - Trimarchi, H. AU - Barratt, J. AU - Cattran, D. C. PY - 2017 DA - 2017// TI - Oxford classification of IgA nephropathy 2016—the role of crescentic lesions: an update from the IgA Nephropathy Classification Working Group JO - Kidney Int VL - 91 UR - https://doi.org/10.1016/j.kint.2017.02.003 DO - 10.1016/j.kint.2017.02.003 ID - Trimarchi2017 ER - TY - JOUR PY - 2012 DA - 2012// TI - KDIGO clinical practice guideline for glomerulonephritis JO - Kidney Int Suppl VL - 2 UR - https://doi.org/10.1038/kisup.2012.23 DO - 10.1038/kisup.2012.23 ID - ref8 ER - TY - JOUR AU - Yang, P. AU - Chen, X. AU - Zeng, L. AU - Hao, H. AU - Xu, G. PY - 2017 DA - 2017// TI - The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis JO - Oncotarget VL - 8 ID - Yang2017 ER - TY - JOUR AU - Tesar, V. AU - Troyanov, S. AU - Bellur, S. PY - 2015 DA - 2015// TI - Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA Study JO - J Am Soc Nephrol VL - 26 UR - https://doi.org/10.1681/ASN.2014070697 DO - 10.1681/ASN.2014070697 ID - Tesar2015 ER - TY - JOUR AU - Rauen, T. AU - Eitner, F. AU - Fitzner, C. PY - 2015 DA - 2015// TI - Intensive supportive care plus immunosuppression in IgA nephropathy JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1415463 DO - 10.1056/NEJMoa1415463 ID - Rauen2015 ER - TY - JOUR AU - Lv, J. AU - Zhang, H. AU - Wong, M. G. PY - 2017 DA - 2017// TI - Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy JO - JAMA VL - 318 UR - https://doi.org/10.1001/jama.2017.9362 DO - 10.1001/jama.2017.9362 ID - Lv2017 ER - TY - JOUR AU - Tang, S. C. AU - Tang, A. W. AU - Wong, S. S. AU - Leung, J. C. AU - Ho, Y. W. AU - Lai, K. N. PY - 2010 DA - 2010// TI - Long-term study of mycophenolate mofetil treatment in IgA nephropathy JO - Kidney Int VL - 77 UR - https://doi.org/10.1038/ki.2009.499 DO - 10.1038/ki.2009.499 ID - Tang2010 ER - TY - JOUR AU - Hou, J. H. AU - Le, W. B. AU - Chen, N. PY - 2017 DA - 2017// TI - Mycophenolate Mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial JO - Am J Kidney Dis VL - 69 UR - https://doi.org/10.1053/j.ajkd.2016.11.027 DO - 10.1053/j.ajkd.2016.11.027 ID - Hou2017 ER - TY - JOUR AU - Song, Y. H. AU - Cai, G. Y. AU - Xiao, Y. F. PY - 2017 DA - 2017// TI - Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis JO - BMC Nephrol VL - 18 UR - https://doi.org/10.1186/s12882-017-0467-z DO - 10.1186/s12882-017-0467-z ID - Song2017 ER - TY - JOUR AU - Lafayette, R. A. AU - Canetta, P. A. AU - Rovin, B. H. PY - 2017 DA - 2017// TI - A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction JO - J Am Soc Nephrol VL - 28 UR - https://doi.org/10.1681/ASN.2016060640 DO - 10.1681/ASN.2016060640 ID - Lafayette2017 ER - TY - JOUR AU - Fellstrom, B. C. AU - Barratt, J. AU - Cook, H. PY - 2017 DA - 2017// TI - Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomized, placebo-controlled phase 2b trial JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(17)30550-0 DO - 10.1016/S0140-6736(17)30550-0 ID - Fellstrom2017 ER - TY - JOUR AU - Wang, Y. J. AU - He, L. Q. AU - Sun, W. AU - Lu, Y. AU - Wang, X. Q. AU - Zhang, P. Q. PY - 2012 DA - 2012// TI - Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial JO - J Ethnopharmacol VL - 139 UR - https://doi.org/10.1016/j.jep.2011.12.009 DO - 10.1016/j.jep.2011.12.009 ID - Wang2012 ER - TY - JOUR AU - Zhong, Y. AU - Menon, M. C. AU - Deng, Y. AU - Chen, Y. AU - He, J. C. PY - 2015 DA - 2015// TI - Recent advances in traditional Chinese medicine for kidney disease JO - Am J Kidney Dis VL - 66 UR - https://doi.org/10.1053/j.ajkd.2015.04.013 DO - 10.1053/j.ajkd.2015.04.013 ID - Zhong2015 ER - TY - JOUR AU - Peng, T. AU - Yang, X. D. AU - Li, D. R. AU - Guo, L. AU - Xia, Q. AU - Hu, Z. PY - 2010 DA - 2010// TI - Observation of effect of Huang Kui capsule combined with valsartan in the treatment of IgA nephropathy JO - Chin J Integr Tradit West Nephrol VL - 11 ID - Peng2010 ER - TY - JOUR AU - Zhang, L. AU - Li, P. AU - Xing, C. Y. AU - Zhao, J. Y. AU - He, Y. N. PY - 2014 DA - 2014// TI - Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial JO - Am J Kidney Dis VL - 64 UR - https://doi.org/10.1053/j.ajkd.2014.01.431 DO - 10.1053/j.ajkd.2014.01.431 ID - Zhang2014 ER - TY - STD TI - Shen LI, Mo-yang DONG, Xiang-rong RAO, et al. Effect of Yiqi Qingjie Formula combined with immunosuppressive therapies on IgA nephropathy with high-risk factor: a propensity score matching analysis. Chin J Integr Tradit West Med. 2019. https://doi.org/10.7661/j.cjim.20190429.010 [Article in Chinese with English abstract]. ID - ref22 ER - TY - JOUR AU - Mitsuiki, K. AU - Harada, A. AU - Okura, T. AU - Higaki, J. PY - 2007 DA - 2007// TI - Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide JO - Clin Exp Nephrol VL - 11 UR - https://doi.org/10.1007/s10157-007-0497-0 DO - 10.1007/s10157-007-0497-0 ID - Mitsuiki2007 ER - TY - JOUR AU - Chan, A. W. AU - Tetzlaff, J. M. AU - Gotzsche, P. C. PY - 2013 DA - 2013// TI - SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials JO - BMJ VL - 346 UR - https://doi.org/10.1136/bmj.e7586 DO - 10.1136/bmj.e7586 ID - Chan2013 ER - TY - JOUR AU - Kim, J. K. AU - Kim, J. H. AU - Lee, S. C. PY - 2012 DA - 2012// TI - Clinical features and outcomes of IgA nephropathy with nephrotic syndrome JO - Clin J Am Soc Nephrol VL - 7 UR - https://doi.org/10.2215/CJN.04820511 DO - 10.2215/CJN.04820511 ID - Kim2012 ER - TY - JOUR AU - Zhang, L. AU - Li, P. AU - Xing, C. Y. PY - 2014 DA - 2014// TI - Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial JO - Am J Kidney Dis VL - 64 UR - https://doi.org/10.1053/j.ajkd.2014.01.431 DO - 10.1053/j.ajkd.2014.01.431 ID - Zhang2014 ER -